Vanda Pharmaceuticals settles Fanapt® patent litigation with Taro
Vanda Pharmaceuticals announced it has entered into a License Agreement with Taro Pharmaceuticals to resolve Vanda's patent litigation against Taro regarding Taro's Abbreviated New Drug Application seeking approval of its generic version of Vanda's Fanapt® (iloperidone). October 24, 2016